Literature DB >> 17313422

Botulinum toxin A in the overactive bladder: current status and future directions.

Roger Dmochowski1, Peter K Sand.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17313422     DOI： 10.1111/j.1464-410X.2007.06575.x

Source DB:  PubMed          Journal:  BJU Int        ISSN： 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  26 in total

1.  Treatment satisfaction and goal attainment with onabotulinumtoxinA in patients with incontinence due to idiopathic OAB.

Authors:  Linda Brubaker; Angelo Gousse; Peter Sand; Catherine Thompson; Vaishali Patel; Jihao Zhou; Brenda Jenkins; Karl-Dietrich Sievert
Journal:  Int Urogynecol J       Date:  2012-01-25       Impact factor: 2.894

Review 2.  New insights into the pharmacology of the bladder.

Authors:  Ann T Hanna-Mitchell; Lori A Birder
Journal:  Curr Opin Urol       Date:  2008-07       Impact factor: 2.309

3.  A morphological evaluation of botulinum neurotoxin A injections into the detrusor muscle using magnetic resonance imaging.

Authors:  Ulrich Mehnert; Sönke Boy; Marius Schmid; André Reitz; Alexander von Hessling; Juerg Hodler; Brigitte Schurch
Journal:  World J Urol       Date:  2009-01-15       Impact factor: 4.226

4.  Detection of botulinum neurotoxin serotype A, B, and F proteolytic activity in complex matrices with picomolar to femtomolar sensitivity.

Authors:  F Mark Dunning; Daniel R Ruge; Timothy M Piazza; Larry H Stanker; Füsûn N Zeytin; Ward C Tucker
Journal:  Appl Environ Microbiol       Date:  2012-08-24       Impact factor: 4.792

5.  Isolation and quantification of botulinum neurotoxin from complex matrices using the BoTest matrix assays.

Authors:  F Mark Dunning; Timothy M Piazza; Füsûn N Zeytin; Ward C Tucker
Journal:  J Vis Exp       Date:  2014-03-03       Impact factor: 1.355

Review 6.  [Anticholinergic agents for overactive bladder syndrome: current head-to-head comparison].

Authors:  M Goepel; D Schultz-Lampel
Journal:  Urologe A       Date:  2011-07       Impact factor: 0.639

7.  Objective differences between overactive bladder patients with and without urodynamically proven detrusor overactivity.

Authors:  Michael L Guralnick; Gwen Grimsby; Michael Liss; Aniko Szabo; R Corey O'Connor
Journal:  Int Urogynecol J       Date:  2009-11-12       Impact factor: 2.894

8.  The surgical management of the refractory overactive bladder.

Authors:  Nikhil Vasdev; Benjamin D Biles; Raveen Sandher; Tahseen S Hasan
Journal:  Indian J Urol       Date:  2010-04

Review 9.  Therapeutic receptor targets for lower urinary tract dysfunction.

Authors:  Naoki Yoshimura; Yasuhiro Kaiho; Minoru Miyazato; Takakazu Yunoki; Changfeng Tai; Michael B Chancellor; Pradeep Tyagi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-11-21       Impact factor: 3.000

10.  Botulinum a toxin/dimethyl sulfoxide bladder instillations for women with refractory idiopathic detrusor overactivity: a phase 1/2 study.

Authors:  Steven P Petrou; Alexander S Parker; Julia E Crook; Alexandra Rogers; Dorothea Metz-Kudashick; David D Thiel
Journal:  Mayo Clin Proc       Date:  2009-08       Impact factor: 7.616
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.